Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Emergence and maintenance of multidrug-resistant Escherichia coli of canine origin harbouring a blaCMY-2-IncI1/ST65 plasmid and topoisomerase mutations.

Vingopoulou EI, Siarkou VI, Batzias G, Kaltsogianni F, Sianou E, Tzavaras I, Koutinas A, Saridomichelakis MN, Sofianou D, Tzelepi E, Miriagou V.

J Antimicrob Chemother. 2014 Aug;69(8):2076-80. doi: 10.1093/jac/dku090. Epub 2014 Apr 9.

PMID:
24722836
2.

Accumulation of carbapenem resistance mechanisms in VIM-2-producing Pseudomonas aeruginosa under selective pressure.

Meletis G, Vavatsi N, Exindari M, Protonotariou E, Sianou E, Haitoglou C, Sofianou D, Pournaras S, Diza E.

Eur J Clin Microbiol Infect Dis. 2014 Feb;33(2):253-8. doi: 10.1007/s10096-013-1952-3. Epub 2013 Sep 6.

PMID:
24062236
3.

Trimebutine as a potential antimicrobial agent: a preliminary in vitro approach.

Kountouras J, Sofianou D, Gavalas E, Sianou E, Zavos C, Meletis G, Tsiaousi E.

Hippokratia. 2012 Oct;16(4):347-9.

4.

Mechanisms responsible for the emergence of carbapenem resistance in Pseudomonas aeruginosa.

Meletis G, Exindari M, Vavatsi N, Sofianou D, Diza E.

Hippokratia. 2012 Oct;16(4):303-7.

5.

Vancomycin-resistant Enterococcus outbreak in a neonatal intensive care unit: epidemiology, molecular analysis and risk factors.

Iosifidis E, Evdoridou I, Agakidou E, Chochliourou E, Protonotariou E, Karakoula K, Stathis I, Sofianou D, Drossou-Agakidou V, Pournaras S, Roilides E.

Am J Infect Control. 2013 Oct;41(10):857-61. doi: 10.1016/j.ajic.2013.02.005. Epub 2013 May 11.

PMID:
23669299
6.

Polyclonal outbreak of vancomycin-resistant Enterococcus faecium in a pediatric oncology department.

Iosifidis E, Karakoula K, Protonotariou E, Kaperoni M, Matapa E, Pournaras S, Koliouskas D, Sofianou D, Roilides E.

J Pediatr Hematol Oncol. 2012 Oct;34(7):511-6.

PMID:
22627577
7.

Diversity of vanA-type vancomycin-resistant Enterococcus faecium isolated from broilers, poultry slaughterers and hospitalized humans in Greece.

Tzavaras I, Siarkou VI, Zdragas A, Kotzamanidis C, Vafeas G, Bourtzi-Hatzopoulou E, Pournaras S, Sofianou D.

J Antimicrob Chemother. 2012 Aug;67(8):1811-8. doi: 10.1093/jac/dks166. Epub 2012 May 10.

PMID:
22577103
8.

Microbiological and molecular characteristics of carbapenemase-producing Klebsiella pneumoniae endemic in a tertiary Greek hospital during 2004-2010.

Zagorianou A, Sianou E, Iosifidis E, Dimou V, Protonotariou E, Miyakis S, Roilides E, Sofianou D.

Euro Surveill. 2012 Feb 16;17(7). pii: 20088.

9.

A cautionary case of microbial solidarity: concurrent isolation of VIM-1-producing Klebsiella pneumoniae, Escherichia coli and Enterobacter cloacae from an infected wound.

Sianou E, Kristo I, Petridis M, Apostolidis K, Meletis G, Miyakis S, Sofianou D.

J Antimicrob Chemother. 2012 Jan;67(1):244-6. doi: 10.1093/jac/dkr402. Epub 2011 Oct 3. No abstract available.

PMID:
21969331
10.

Comparative evaluation of combined-disk tests using different boronic acid compounds for detection of klebsiella pneumoniae carbapenemase-producing enterobacteriaceae clinical isolates.

Tsakris A, Themeli-Digalaki K, Poulou A, Vrioni G, Voulgari E, Koumaki V, Agodi A, Pournaras S, Sofianou D.

J Clin Microbiol. 2011 Aug;49(8):2804-9. doi: 10.1128/JCM.00666-11. Epub 2011 Jun 1.

11.

Colistin heteroresistance in carbapenemase-producing Klebsiella pneumoniae.

Meletis G, Tzampaz E, Sianou E, Tzavaras I, Sofianou D.

J Antimicrob Chemother. 2011 Apr;66(4):946-7. doi: 10.1093/jac/dkr007. Epub 2011 Jan 25. No abstract available.

PMID:
21393203
12.

Outcome of urinary tract infections caused by extended spectrum β-lactamase-producing Enterobacteriaceae in children.

Tratselas A, Iosifidis E, Ioannidou M, Saoulidis S, Kollios K, Antachopoulos C, Sofianou D, Roilides EJ.

Pediatr Infect Dis J. 2011 Aug;30(8):707-10. doi: 10.1097/INF.0b013e31820d7ec4.

PMID:
21248655
13.

Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.

Mouloudi E, Protonotariou E, Zagorianou A, Iosifidis E, Karapanagiotou A, Giasnetsova T, Tsioka A, Roilides E, Sofianou D, Gritsi-Gerogianni N.

Infect Control Hosp Epidemiol. 2010 Dec;31(12):1250-6. doi: 10.1086/657135. Epub 2010 Oct 25.

PMID:
20973725
14.

Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 beta-lactamase resistant to colistin.

Kontopoulou K, Protonotariou E, Vasilakos K, Kriti M, Koteli A, Antoniadou E, Sofianou D.

J Hosp Infect. 2010 Sep;76(1):70-3. doi: 10.1016/j.jhin.2010.03.021. Epub 2010 Jun 17.

PMID:
20705205
15.

Emergence of Klebsiella pneumoniae carrying bla(VIM) and bla(KPC) genes.

Meletis G, Tzampaz E, Protonotariou E, Sofianou D.

Hippokratia. 2010 Apr;14(2):139-40.

16.

A simple phenotypic method for the differentiation of metallo-beta-lactamases and class A KPC carbapenemases in Enterobacteriaceae clinical isolates.

Tsakris A, Poulou A, Pournaras S, Voulgari E, Vrioni G, Themeli-Digalaki K, Petropoulou D, Sofianou D.

J Antimicrob Chemother. 2010 Aug;65(8):1664-71. doi: 10.1093/jac/dkq210. Epub 2010 Jun 11.

PMID:
20542902
17.

Trends in antimicrobial resistance of clinical isolates of Enterococcus faecalis and Enterococcus faecium in Greece between 2002 and 2007.

Protonotariou E, Dimitroulia E, Pournaras S, Pitiriga V, Sofianou D, Tsakris A.

J Hosp Infect. 2010 Jul;75(3):225-7. doi: 10.1016/j.jhin.2009.12.007. Epub 2010 Apr 8.

PMID:
20381193
18.

Use of boronic acid disk tests to detect extended- spectrum beta-lactamases in clinical isolates of KPC carbapenemase-possessing enterobacteriaceae.

Tsakris A, Poulou A, Themeli-Digalaki K, Voulgari E, Pittaras T, Sofianou D, Pournaras S, Petropoulou D.

J Clin Microbiol. 2009 Nov;47(11):3420-6. doi: 10.1128/JCM.01314-09. Epub 2009 Sep 2.

19.

Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece.

Pournaras S, Protonotariou E, Voulgari E, Kristo I, Dimitroulia E, Vitti D, Tsalidou M, Maniatis AN, Tsakris A, Sofianou D.

J Antimicrob Chemother. 2009 Aug;64(2):348-52. doi: 10.1093/jac/dkp207. Epub 2009 Jun 13.

PMID:
19525514
20.

Carbapenem-resistant Escherichia coli carrying the blaVIM-1 gene in the community.

Vitti D, Protonotariou E, Sofianou D.

Int J Antimicrob Agents. 2009 Aug;34(2):187-8. doi: 10.1016/j.ijantimicag.2009.02.011. Epub 2009 Mar 25. No abstract available.

PMID:
19324525
21.

Molecular epidemiology of outbreak-related pseudomonas aeruginosa strains carrying the novel variant blaVIM-17 metallo-beta-lactamase gene.

Siarkou VI, Vitti D, Protonotariou E, Ikonomidis A, Sofianou D.

Antimicrob Agents Chemother. 2009 Apr;53(4):1325-30. doi: 10.1128/AAC.01230-08. Epub 2009 Jan 21.

22.

Evaluation of boronic acid disk tests for differentiating KPC-possessing Klebsiella pneumoniae isolates in the clinical laboratory.

Tsakris A, Kristo I, Poulou A, Themeli-Digalaki K, Ikonomidis A, Petropoulou D, Pournaras S, Sofianou D.

J Clin Microbiol. 2009 Feb;47(2):362-7. doi: 10.1128/JCM.01922-08. Epub 2008 Dec 10.

23.

First identification of VIM-1-producing Citrobacter freundii in Greece.

Protonotariou E, Tsalidou M, Vitti D, Kalogeridis A, Sofianou D.

Int J Antimicrob Agents. 2008 Nov;32(5):460-1. doi: 10.1016/j.ijantimicag.2008.05.008. Epub 2008 Aug 19. No abstract available.

PMID:
18715763
24.

Differential correlation between rates of antimicrobial drug consumption and prevalence of antimicrobial resistance in a tertiary care hospital in Greece.

Iosifidis E, Antachopoulos C, Tsivitanidou M, Katragkou A, Farmaki E, Tsiakou M, Kyriazi T, Sofianou D, Roilides E.

Infect Control Hosp Epidemiol. 2008 Jul;29(7):615-22. doi: 10.1086/589333.

PMID:
18624668
25.

Emergence of the plasmid-mediated quinolone resistance gene qnrS1 in Escherichia coli isolates in Greece.

Vasilaki O, Ntokou E, Ikonomidis A, Sofianou D, Frantzidou F, Alexiou-Daniel S, Maniatis AN, Pournaras S.

Antimicrob Agents Chemother. 2008 Aug;52(8):2996-7. doi: 10.1128/AAC.00325-08. Epub 2008 May 19. No abstract available.

26.

Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules.

Polyzos SA, Kita M, Efstathiadou Z, Poulakos P, Slavakis A, Sofianou D, Flaris N, Leontsini M, Kourtis A, Avramidis A.

J Cancer Res Clin Oncol. 2008 Sep;134(9):953-60. doi: 10.1007/s00432-008-0373-7. Epub 2008 Mar 8.

PMID:
18327610
27.

Outbreak caused by a multidrug-resistant Klebsiella pneumoniae clone carrying blaVIM-12 in a university hospital.

Tokatlidou D, Tsivitanidou M, Pournaras S, Ikonomidis A, Tsakris A, Sofianou D.

J Clin Microbiol. 2008 Mar;46(3):1005-8. doi: 10.1128/JCM.01573-07. Epub 2008 Jan 16.

28.

In vitro activity of tigecycline against metallo-beta-lactamase-producing Enterobacteriaceae.

Pliatsika V, Afkou Z, Protonotariou E, Sofianou D.

J Antimicrob Chemother. 2007 Dec;60(6):1406-7. Epub 2007 Oct 25. No abstract available.

PMID:
17962216
29.

Nationwide surveillance of Streptococcus pneumoniae in Greece: patterns of resistance and serotype epidemiology.

Poulakou G, Katsarolis I, Matthaiopoulou I, Tsiodras S, Kanavaki S, Hatzaki D, Roilides E, Sofianou D, Kavaliotis I, Kansouzidou A, Kafetzis DA, Paraskakis I, Foustoukou M, Daikos GL, Syriopoulou V, Pangalis A, Leveidiotou S, Giamarellou H; Hellenic Study Group for the Susceptibility of Streptococcus pneumoniae.

Int J Antimicrob Agents. 2007 Jul;30(1):87-92. Epub 2007 May 30.

PMID:
17540542
30.

First occurrence of an Escherichia coli clinical isolate producing the VIM-1/VIM-2 hybrid metallo-beta-lactamase VIM-12.

Ikonomidis A, Labrou M, Afkou Z, Maniatis AN, Sofianou D, Tsakris A, Pournaras S.

Antimicrob Agents Chemother. 2007 Aug;51(8):3038-9. Epub 2007 May 21. No abstract available.

31.

Fungal colonization in the neonatal intensive care unit: risk factors, drug susceptibility, and association with invasive fungal infections.

Farmaki E, Evdoridou J, Pouliou T, Bibashi E, Panagopoulou P, Filioti J, Benos A, Sofianou D, Kremenopoulos G, Roilides E.

Am J Perinatol. 2007 Feb;24(2):127-35. Epub 2007 Feb 15.

PMID:
17304423
32.

Acquisition of imipenem-resistant Acinetobacter baumannii in a pediatric intensive care unit: A case-control study.

Katragkou A, Kotsiou M, Antachopoulos C, Benos A, Sofianou D, Tamiolaki M, Roilides E.

Intensive Care Med. 2006 Sep;32(9):1384-91. Epub 2006 Jun 21.

PMID:
16788807
33.

VIM-1 metallo-beta-lactamase in Acinetobacter baumannii.

Tsakris A, Ikonomidis A, Pournaras S, Tzouvelekis LS, Sofianou D, Legakis NJ, Maniatis AN.

Emerg Infect Dis. 2006 Jun;12(6):981-3.

34.

CTX-M-1 extended-spectrum beta-lactamase-producing Proteus mirabilis in Greece.

Karapavlidou P, Sofianou D, Manolis EN, Pournaras S, Tsakris A.

Microb Drug Resist. 2005 Winter;11(4):351-4.

PMID:
16359194
35.

VIM-2 metallo-beta-lactamase in Achromobacter xylosoxidans in Europe.

Sofianou D, Markogiannakis A, Metzidie E, Pournaras S, Tsakris A.

Eur J Clin Microbiol Infect Dis. 2005 Dec;24(12):854-5. No abstract available.

PMID:
16333608
36.

Spread of an unusual penicillin- and imipenem-resistant but ampicillin-susceptible phenotype among Enterococcus faecalis clinical isolates.

Metzidie E, Manolis EN, Pournaras S, Sofianou D, Tsakris A.

J Antimicrob Chemother. 2006 Jan;57(1):158-60. Epub 2005 Nov 24. No abstract available.

PMID:
16308417
37.

Outbreaks in distinct regions due to a single Klebsiella pneumoniae clone carrying a bla VIM-1 metallo-{beta}-lactamase gene.

Ikonomidis A, Tokatlidou D, Kristo I, Sofianou D, Tsakris A, Mantzana P, Pournaras S, Maniatis AN.

J Clin Microbiol. 2005 Oct;43(10):5344-7.

38.

A fatal case of Ludwig's angina and mediastinitis caused by an unusual microorganism, Gemella morbillorum.

Sofianou D, Peftoulidou M, Manolis EN, Sofianos E, Tsakris A.

Scand J Infect Dis. 2005;37(5):367-9.

PMID:
16051575
39.

Neonatal candidiasis: analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates.

Roilides E, Farmaki E, Evdoridou J, Dotis J, Hatziioannidis E, Tsivitanidou M, Bibashi E, Filioti I, Sofianou D, Gil-Lamaignere C, Mueller FM, Kremenopoulos G.

Eur J Clin Microbiol Infect Dis. 2004 Oct;23(10):745-50.

PMID:
15605181
40.

CTX-M-type beta-lactamases affect community Escherichia coli treatment, Greece.

Pournaras S, Ikonomidis A, Sofianou D, Tsakris A, Maniatis AN.

Emerg Infect Dis. 2004 Jun;10(6):1163-4. No abstract available.

41.

Substantially increased faecal carriage of vancomycin-resistant enterococci in a tertiary Greek hospital after a 4 year time interval.

Sofianou D, Pournaras S, Giosi M, Polyzou A, Maniatis AN, Tsakris A.

J Antimicrob Chemother. 2004 Jul;54(1):251-4. Epub 2004 May 26.

PMID:
15163658
42.

Sero epidemiology of Bordetella pertussis immune responses in a healthy population in northern Greece.

Polyzou A, Pournaras S, Dafni U, Sofianou D, Christeli E, Patrinos S, Tsakris A.

J Clin Lab Anal. 2004;18(3):211-4.

43.

Soft-tissue abscess involving Actinomyces odontolyticus and two Prevotella species in an intravenous drug abuser.

Sofianou D, Avgoustinakis E, Dilopoulou A, Pournaras S, Tsirakidis G, Tsakris A.

Comp Immunol Microbiol Infect Dis. 2004 Mar;27(2):75-9.

PMID:
14690717
44.

Spread of low-level carbapenem-resistant Acinetobacter baumannii clones in a tertiary care Greek hospital.

Tsakris A, Tsioni C, Pournaras S, Polyzos S, Maniatis AN, Sofianou D.

J Antimicrob Chemother. 2003 Dec;52(6):1046-7. Epub 2003 Oct 29. No abstract available.

PMID:
14585857
45.

Characterization of Klebsiella pneumoniae clinical strains producing a rare extended-spectrum beta-lactamase (IBC-1).

Vourli S, Tzouvelekis LS, Tzelepi E, Kartali G, Kontopoulou C, Sofianou D, Tzouvelekis LS.

Int J Antimicrob Agents. 2003 May;21(5):495-7. No abstract available.

PMID:
12727088
46.

Fungal peritonitis complicating peritoneal dialysis during an 11-year period: report of 46 cases.

Bibashi E, Memmos D, Kokolina E, Tsakiris D, Sofianou D, Papadimitriou M.

Clin Infect Dis. 2003 Apr 1;36(7):927-31. Epub 2003 Mar 18.

PMID:
12652395
47.

Extended-spectrum beta-lactamase types in Klebsiella pneumoniae and Escherichia coli in two Greek hospitals.

Tzelepi E, Magana Ch, Platsouka E, Sofianou D, Paniara O, Legakis NJ, Vatopoulos AC, Tzouvelekis LS.

Int J Antimicrob Agents. 2003 Mar;21(3):285-8.

PMID:
12636993
48.

Candida tropicalis in a neonatal intensive care unit: epidemiologic and molecular analysis of an outbreak of infection with an uncommon neonatal pathogen.

Roilides E, Farmaki E, Evdoridou J, Francesconi A, Kasai M, Filioti J, Tsivitanidou M, Sofianou D, Kremenopoulos G, Walsh TJ.

J Clin Microbiol. 2003 Feb;41(2):735-41.

49.

Three cases of uncommon fungal peritonitis in patients undergoing peritoneal dialysis.

Bibashi E, Kokolina E, Sigler L, Sofianou D, Tsakiris D, Visvardis G, Papadimitriou M, Memmos D.

Perit Dial Int. 2002 Jul-Aug;22(4):523-5. No abstract available.

PMID:
12322828
50.

Outbreak of infections caused by Enterobacter cloacae producing the integron-associated beta-lactamase IBC-1 in a neonatal intensive care unit of a Greek hospital.

Kartali G, Tzelepi E, Pournaras S, Kontopoulou C, Kontos F, Sofianou D, Maniatis AN, Tsakris A.

Antimicrob Agents Chemother. 2002 May;46(5):1577-80.

Supplemental Content

Loading ...
Support Center